Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02496730

Ligand	Ligand name	Chain	PDB	Tanimoto
RNP	(1E,2R)-1-(ISOPROPYLIMINO)-3-(1-NAPHTHYLOXY)PROPAN-2-OL	X	1H46	0.72
XX7	2-{[(2S)-2-HYDROXY-3-(9-PHENANTHRYLOXY)PROPYL]AMINO}PROPANE-1,3-DIOL	A	2V3R	0.73
OHT	4-HYDROXYTAMOXIFEN	A	3ERT	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B	1S9Q	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B	1VJB	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B,C,P,R	2JF9	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B,C,D,E,F	2GPV	0.7
OHT	4-HYDROXYTAMOXIFEN	A	2GPU	0.7
OHT	4-HYDROXYTAMOXIFEN	A	2P7Z	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B	2BJ4	0.7
OHT	4-HYDROXYTAMOXIFEN	A,B	2FSZ	0.7
5PP	5-PENTYL-2-PHENOXYPHENOL	A,B,C,D,E,F	2B36	0.71
8PS	5-OCTYL-2-PHENOXYPHENOL	A,B,C,D,E,F	2B37	0.71
ESM	1,3,5(10)-ESTRATRIEN-2,3,17-BETA-TRIOL 2-METHYL ETHER	A	1LHW	0.79
XX6	2-{[(2R)-2-HYDROXY-3-(9-PHENANTHRYLOXY)PROPYL]AMINO}PROPANE-1,3-DIOL	A	2V3I	0.73
SLX	(13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol	A	3FW9	0.82
MOI	(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL	H,L	1Q0Y	0.89
C3D	(5R,6S)-6-PHENYL-5-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]-5,6,7,8-TETRAHYDRONAPHTHALEN-2-OL	A	2OUZ	0.76
CM4	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL	A	1YIM	0.73
ESL	ESTRIOL	A	1X8V	0.71
E3O	(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL	A	2J7Y	0.71
CMZ	(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol	A	2OF0	0.7
AB8	(1S,3R,8AS)-8-(2-{(4S,6S)-3-(4-HYDROXY-3-METHOXYBENZYL)-4-[2-(METHYLAMINO)-2-OXOETHYL]-2-OXO-1,3-OXAZINAN-6-YL}ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL (2R)-2-METHYLBUTANOATE	A,B	1XDG	0.7
PO1	(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE	A	2GD8	0.71
A88	(5R,6R)-2,4-BIS-(4-HYDROXY-3-METHOXYBENZYL)-1,5-DIBENZYL-3-OXO-6-HYDROXY-1,2,4-TRIAZACYCLOHEPTANE	A	1PRO	0.71
AOE	N-BUTYL-11-[(7R,8R,9S,13S,14S,17S)-3,17-DIHYDROXY-13-METHYL-7,8,9,11,12,13,14,15,16,17-DECAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-7-YL]-N-METHYLUNDECANAMIDE	A	1HJ1	0.72
ECS	2,3,17BETA-TRIHYDROXY-1,3,5(10)-ESTRATRIENE	A,B,C,D	2BW7	0.73
SNP	1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL	A	1DY4	0.74
GNT	(-)-GALANTHAMINE	A	1DX6	0.81
GNT	(-)-GALANTHAMINE	A	1QTI	0.81
GNT	(-)-GALANTHAMINE	A,B,C,D,E	2PH9	0.81
GNT	(-)-GALANTHAMINE	A,B	1W76	0.81
GNT	(-)-GALANTHAMINE	A	1W6R	0.81
TXF	(Z)-4-(1-{4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL}-5-HYDROXY-2-PHENYLPENT-1-ENYL)PHENOL	A,B,C,D,E	2EWP	0.72
YR3	(2S)-3-{4-[1-ethyl-1-(4-{[(2R)-2-hydroxy-3,3-dimethylbutyl]oxy}-3-methylphenyl)propyl]-2-methylphenoxy}propane-1,2-diol	A	2ZFX	0.7
4SR	(4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN-2-ONE	A,B	1XN0	0.7
REN	(S)-reticuline	A	3FWA	0.83
REN	(S)-reticuline	A	3D2D	0.83
NLX	(5A,17R)-4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-6-OXO-17-(2-PROPENYL)-MORPHINANIUM	A,B,C,D,E,F,G,H,I,J,K,L	1MX9	0.76
DPD		A,B	1QIW	0.72
DPD		A	1QIV	0.72
ROL	ROLIPRAM	A,B,C,D	1OYN	0.7
ROL	ROLIPRAM	A,B	1XMY	0.7
ROL	ROLIPRAM	A,B,C,D	1Q9M	0.7
ROL	ROLIPRAM	A,B	1RO6	0.7
ROL	ROLIPRAM	A,B	1XN0	0.7
ROL	ROLIPRAM	A,B	1TBB	0.7
ANM	ANISOMYCIN	1,2,4,A,B,C,D,E,J,K,L,M,N,O,P,R,S,T,U,V,Z	1K73	0.73
ANM	ANISOMYCIN	0,1,3,9,A,B,C,F,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	3CC4	0.73